NOVATEK

Legal Proceedings Report • Oct 22, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7406Q

PAO Novatek

22 October 2019

For immediate release

NOVATEK Issues Update on Arc7 LNG Tankers

Moscow, 22 October 2019. PAO NOVATEK ("NOVATEK" and/or the "Company") today announced that Yamal LNG has received notification from TC LNG Shipping L.L.C. ("TC LNG"), the joint-venture owning the Arc7 ice-class tankers, that joint-venture is no longer considered a "Blocked Person" under the US Department of the Treasury's Office of Foreign Asset Control or "OFAC" rules.

TC LNG, a joint-venture between Teekay LNG and China LNG Shipping (Holdings) Limited, owns Arc7 LNG tankers that are conducting LNG shipments for the Yamal LNG project in the normal course of business.

***

For more information please visit: www.novatek.ru

Press Service	Investor Relations
+7 (495) 721 2207	+7 (495) 730 6013
press@novatek.ru	ir@novatek.ru

***

PAO NOVATEK is the largest independent natural gas producer in Russia, and in 2017, entered the global LNG market by successfully launching the Yamal LNG project. Founded in 1994, the Company is engaged in the exploration, production, processing and marketing of natural gas and liquid hydrocarbons. The Company's upstream activities are concentrated mainly in the prolific Yamal-Nenets Autonomous Region, which is the world's largest natural gas producing area and accounts for approximately 80% of Russia's natural gas production and approximately 15% of the world's gas production. NOVATEK is a public joint stock company established under the laws of the Russian Federation. The Company's shares are listed in Russia on Moscow Exchange (MOEX) and the London Stock Exchange (LSE) under the ticker symbol «NVTK».

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCFEAFEEFUSEFS